oncology
Cancer care

Early corticosteroid use impairs checkpoint inhibitor efficacy

Early initiation of corticosteroid during immune checkpoint inhibitor treatment may hamper efficacy, according to US and Australian researchers While corticosteroids are commonly used to manage immune-related adverse effects (irAEs), there is uncertainty about their impact on immunotherapy efficacy, they wrote in in the Journal for ImmunoTherapy of Cancer. Their study  therefore reviewed survival outcomes and ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic